Measurement of Lipogenic Flux by Deuterium Resolved Mass Spectrometry Via Non-invasive Breath Analysis
Launched by UNIVERSITY CHILDREN'S HOSPITAL BASEL · Mar 1, 2022
Trial Information
Current as of June 22, 2025
Completed
Keywords
ClinConnect Summary
The study objective is to measure the DNL by ingestion of a single oral dose of 70% 2H2O at 2 g/kg body-water. The subjects will consume a Yoghurt consisting of 300g of 'Excellence Joghurt Nature gezuckert' which contains 410 Kcal, 28g fat, 34g carbohydrates and 9g protein. The exhaled air of the subjects will be measured several times per hour to analyse de novo lipogenesis (DNL) non-invasive by deuterium resolved mass spectrometry.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy adult volunteers
- • English speaking, or good knowledge of the English language
- • Able to understand the study
- • Able to give informed consent
- Exclusion Criteria:
- • Current pregnancy
About University Children's Hospital Basel
The University Children's Hospital Basel is a leading pediatric healthcare institution committed to advancing child health through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital focuses on developing and evaluating new therapies and interventions tailored to the unique needs of children. With a multidisciplinary team of experienced pediatricians, researchers, and healthcare professionals, the hospital fosters a collaborative environment that prioritizes patient safety and ethical standards. By engaging in cutting-edge clinical trials, the University Children's Hospital Basel aims to enhance treatment options and improve outcomes for pediatric patients, contributing to the broader field of child health and medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Pablo Sinues, Prof. Dr.
Principal Investigator
Universitäts-Kinderspital beider Basel (UKBB)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials